Nuveen Asset Management LLC Cuts Holdings in Liquidia Co. (NASDAQ:LQDA)

Nuveen Asset Management LLC lowered its position in Liquidia Co. (NASDAQ:LQDA) by 7.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 168,735 shares of the company’s stock after selling 13,750 shares during the period. Nuveen Asset Management LLC owned approximately 0.20% of Liquidia worth $1,984,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Catalina Capital Group LLC grew its holdings in Liquidia by 6.5% during the 4th quarter. Catalina Capital Group LLC now owns 18,307 shares of the company’s stock valued at $215,000 after buying an additional 1,125 shares during the last quarter. Rhumbline Advisers raised its position in shares of Liquidia by 3.5% in the 4th quarter. Rhumbline Advisers now owns 80,652 shares of the company’s stock worth $948,000 after buying an additional 2,741 shares during the period. Sigma Planning Corp boosted its holdings in Liquidia by 3.4% in the fourth quarter. Sigma Planning Corp now owns 65,210 shares of the company’s stock valued at $767,000 after acquiring an additional 2,115 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Liquidia by 3.3% in the fourth quarter. Bank of New York Mellon Corp now owns 188,584 shares of the company’s stock valued at $2,218,000 after acquiring an additional 6,034 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC acquired a new position in Liquidia in the fourth quarter valued at $59,000. Institutional investors and hedge funds own 64.54% of the company’s stock.

Liquidia Stock Performance

Shares of NASDAQ LQDA opened at $16.53 on Wednesday. The stock has a fifty day moving average price of $14.78 and a two-hundred day moving average price of $13.84. The firm has a market cap of $1.41 billion, a P/E ratio of -10.14 and a beta of 0.24. Liquidia Co. has a 1 year low of $8.26 and a 1 year high of $19.41.

Liquidia (NASDAQ:LQDA) last announced its quarterly earnings data on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing analysts’ consensus estimates of ($0.42) by ($0.03). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The company had revenue of $3.12 million for the quarter, compared to analyst estimates of $3.23 million. On average, research analysts predict that Liquidia Co. will post -1.51 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have commented on LQDA shares. Wells Fargo & Company boosted their price objective on Liquidia from $20.00 to $23.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 28th. Raymond James boosted their price objective on Liquidia from $27.00 to $29.00 and gave the company a “strong-buy” rating in a report on Friday, May 9th. Needham & Company LLC reissued a “buy” rating and issued a $25.00 price objective on shares of Liquidia in a report on Wednesday, May 28th. BTIG Research reaffirmed a “buy” rating on shares of Liquidia in a report on Tuesday, May 27th. Finally, HC Wainwright upped their target price on Liquidia from $29.00 to $35.00 and gave the company a “buy” rating in a report on Wednesday, May 28th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, Liquidia currently has an average rating of “Moderate Buy” and a consensus target price of $26.67.

Insider Activity

In other news, insider Rajeev Saggar sold 2,450 shares of the stock in a transaction on Monday, April 21st. The stock was sold at an average price of $13.67, for a total value of $33,491.50. Following the completion of the sale, the insider now owns 263,152 shares in the company, valued at $3,597,287.84. This represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, General Counsel Russell Schundler sold 5,964 shares of the company’s stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $80,931.48. Following the completion of the transaction, the general counsel now directly owns 570,301 shares in the company, valued at $7,738,984.57. This trade represents a 1.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,138 shares of company stock worth $450,233 over the last quarter. Corporate insiders own 26.50% of the company’s stock.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).